Sandoz Group AG

Products

Category

Product

Brand

Description

Global Recombinant Proteins Market (BIO254A)

Ziextenzo, G-CSF		Ziextenzo is a PEGylated G-CSF used to treat infection during chemotherapy in 2019. It involves linear PEGylation to increase protein half-life.
Zarxio, Filgrastim-sndz		It is a G-CSF product used to treat neutropenia. It is expressed in E.Coli cells.
Erelzi, Etanercept-szzs		It is a biosimilar product to Enbrel. It is a dimeric fusion protein produced in CHO cells and consists of TNF receptor domains linked to an IgG1 Fc region.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI: Your Say